Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dotarem”

31 trials

Showing 20 of 31 results

Post-approval studies (Phase 4)Study completedNCT02070380
What this trial is testing

Crossover Comparison of MultiHance and Dotarem

Who this might be right for
Brain Disease
Bracco Diagnostics, Inc 179
Post-approval studies (Phase 4)Study completedNCT03602339
What this trial is testing

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

Who this might be right for
Magnetic Resonance Imaging
Bayer 157
Not applicableStudy completedNCT05199792
What this trial is testing

Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA

Who this might be right for
Vascular Diseases
Northwestern University 65
Post-approval studies (Phase 4)Ended earlyNCT01806740
What this trial is testing

DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC

Who this might be right for
Hepatocellular Carcinoma
Guerbet 37
Post-approval studies (Phase 4)Study completedNCT00955617
What this trial is testing

DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

Who this might be right for
Peripheral Arterial Disease
Guerbet 20
Large-scale testing (Phase 3)Study completedNCT01012674
What this trial is testing

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Who this might be right for
Cerebral Arterial Diseases
Guerbet 211
Post-approval studies (Phase 4)Study completedNCT00650845
What this trial is testing

Renal Safety Evaluation After Dotarem®-Enhanced MRI

Who this might be right for
Renal Insufficiency
Guerbet 135
Not applicableUnknownNCT02992847
What this trial is testing

Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)

Who this might be right for
Multiple Sclerosis
Hospices Civils de Lyon 160
Post-approval studies (Phase 4)Study completedNCT03730051
What this trial is testing

Dotarem vs Gadobutrol Contrast for Breast MRI

Who this might be right for
Breast Diseases
University of Massachusetts, Worcester 300
Large-scale testing (Phase 3)Study completedNCT01010932
What this trial is testing

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Who this might be right for
Cerebral Arterial Diseases
Guerbet 222
Large-scale testing (Phase 3)Looking for participantsNCT07348640
What this trial is testing

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

Who this might be right for
Steno-occlusive Disease
Guerbet 315
Large-scale testing (Phase 3)Ended earlyNCT00845702
What this trial is testing

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Who this might be right for
Renal Artery Stenosis
Guerbet 33
Not applicableStudy completedNCT01523873
What this trial is testing

Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)

Who this might be right for
General Safety Profile of DOTAREM
Guerbet 35,921
Early research (Phase 1)Study completedNCT01449266
What this trial is testing

Safety and Dialysability of Dotarem® in Dialysed Patients

Who this might be right for
End-stage Renal Failure
Guerbet 10
Not applicableStudy completedNCT01467271
What this trial is testing

Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration

Who this might be right for
Renal Insufficiency
Guerbet 540
Large-scale testing (Phase 3)Study completedNCT01211873
What this trial is testing

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Who this might be right for
Diagnostic Self EvaluationCentral Nervous System Diseases
Guerbet 416
Post-approval studies (Phase 4)Study completedNCT02411201
What this trial is testing

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Who this might be right for
Magnetic Resonance Imaging
Guerbet 51
Post-approval studies (Phase 4)Study completedNCT02034708
What this trial is testing

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

Who this might be right for
Primary Brain Tumor
Guerbet 279
Post-approval studies (Phase 4)Study completedNCT01026389
What this trial is testing

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Guerbet 189
Large-scale testing (Phase 3)Ended earlyNCT00980681
What this trial is testing

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

Who this might be right for
Renal Disease
Guerbet 13
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation